Physiology of meningeal innervation: Aspects and consequences of chemosensitivity of meningeal nociceptors

Microscopy Research and Technique

Volumn 53, Issue 2, 2001, Pages 138-146

  Ebersberger, Andrea ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

5 HT1B D; Afferents; Brain stem; Dura; Headache; Inflammation; Pain

Indexed keywords

BLOOD PRESSURE;

5-HT1B/D; AFFERENT; ANIMAL MODEL; BRAIN STEM; CHEMOSENSITIVITY; DURA; HEADACHE; INFLAMMATION; NOCICEPTOR; PAIN;

ANIMALS;

BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; NEUROKININ A; NEUROPEPTIDE; PROSTAGLANDIN E2; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SUBSTANCE P;

ARTICLE; BRAIN STEM; CAT; CHEMOSENSITIVITY; DURA MATER; GUINEA PIG; HEADACHE; IN VITRO STUDY; INFLAMMATION; INNERVATION; MENINX; NERVE CONDUCTION; NERVE FIBER C; NOCICEPTIVE RECEPTOR; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SENSORY NERVE; STIMULATION;

EID: 0035871051     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1078     Document Type: Article

References (81)

1. Bevan S, Yeats J. 1991. Protons activate a cation conductance in a subpopulation of rat dorsal root ganglion neurons. J Physiol (Lond) 433:145-161.
2. 2B receptor antagonist. Br J Pharmacol 127:1075-1082.
3. Borges LF, Moskowitz MA. 1983. Do intracranial and extracranial trigeminal afferents represent divergent axon collaterals? Neurosci Lett 35:265-270.
4. Bove GM, Moskowitz MA. 1997. Primary afferent neurons innervating guinea pig dura. J Neurophysiol 77:299-308.
5. Burstein R, Yamamura H, Malick A, Strassman AM. 1998. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964-982.
6. 1 receptor antagonist in the acute treatment of migraine. In: Abstracts of the 12th Migraine Trust Symposium, 1-4 September 1998, London.
7. 1B/D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses. Cephalalgia 18:659-663.
8. 1B/1D agonist. Brit J Pharmacol 126:1478-1486.
9. Davis K, Dostrovsky JO. 1986. Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation. Pain 25:395-401.
10. Davis K, Dostrovsky JO. 1988. Responses of feline trigeminal spinal tract nucleus neurons to stimulation of the middle meningeal artery and sagittal sinus. J Neurophysiol 59:648-666.
11. Dimitriadou V, Buzzi MG, Moskowitz MA, Theoharides TC. 1991. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 44:97-112.
12. Dimitriadou V, Rouleau A, Trung Tuong MD, Newlands GJF, Miller HRP, Luffau G, Schwartz J-C, Garbarg M. 1997. Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience 77:829-839.
13. Dostrovsky JO, Davies KD, Kawakita K. 1991. Central mechanisms of vascular headaches. Can J Physiol Pharmacol 69:652-658.
14. Ebersberger A, Ringkamp M, Reeh PW, Handwerker HO. 1997. Recordings from brain stem neurons responding to chemical stimulation of the subarachnoid space. J Neurophysiol 77:3122-3133.
15. 2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 89:901-907.
16. Ebersberger A, Handwerker HO, Reeh PW. 1999b. Nociceptive neurons in the rat caudal trigeminal nucleus respond to blood plasma perfusion of the subarachnoid space: the involvement of complement. Pain 81:283-288.
17. Ebersberger A, Charbel Issa P, Vanegas H, Schaible H-G. 2000. Differential effects of calcitonin-gene related peptide and calcitonin-gene related peptide 8-37 upon responses to N-Methyl-D-Aspartate or (R,S)-α-Amino-3-hydroxy-5-Methylisoxazole-4-propionate in spinal nociceptive neurons with knee joint input in the rat. Neuroscience 99:171-178.
18. Ebersberger A, Schaible H-G, Averbeck B, Richter F. 2001. Lack of correlation between spreading depression, neurogenic inflammation and nociception that might cause migraine headache. Ann Neurol 49:7-13.
19. Edvinsson L, Goadsby PJ. 1994. Neuropeptides in migraine and cluster headache. Cephalalgia 14:320-327.
20. Edvinsson L, Brodin E, Jansen I, Uddman R. 1988. Neurokinin A in cerebral vessels: characterization, localization and effects in vitro. Regul Pept 20:181-197.
21. Faniciullaci M, Alessandri M, Figini M, Geppetti P, Michelacci S. 1995. Increase in plasma calcitonin gene-related peptide from extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60:119-123.
22. 1C receptor activation: a key step in the initiation of migraine? TIPS 10:307-379.
23. Fozard JR, Kalkman HO. 1994. 5-Hydroxytryptamine (5-HAT) and the initiation of migraine: new perspectives. Naunyn-Schmiedeberg's Arch Pharmacol 350:225-229.
24. Gallai V, Sarchielli P, Floridi A, Franceschini M, Codini M, Glioti G, Trequttrini A, Palumbo R. 1995. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15: 384-390.
25. Habler C. 1929. Über den K- und Ca-Gehalt von Eiter und Exsudaten und seine Beziehungen zum Entzündungsschmerz. Klin Wochensch 8:1569-1572.
26. Headache Classification Committee of The International Headache Society. 1988. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia 8(Suppl 7):1-96.
27. Henry JL, Sessle BJ, Lucier GE, Hu JW. 1980. Effects of Substance P on nociceptive and non-nociceptive brain stem neurons. Pain 8:33-45.
28. Heyer G, Hornstein OP, Handwerker HO. 1991. Reactions to intradermally injected substance P and topically applied mustard oil in atopic dermatitis patients. Acta Derm Venereol 71:291-295.
29. Holzer P. 1988. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24:739-768.
30. Juul R, Hara H, Gisvold SE, Brubakk AO, Fredriksen TA, Waldemar G, Schmidt JF, Ekman R, Edvinsson L. 1995. Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man. Acta Neurochir (Wien) 312:32-41.
31. Kaube H, Hoskin KL, Goadsby PJ. 1992. Activation of the trigeminovascular system by mechanical distention of the superior sagittal sinus in the cat. Cephalalgia 12:133-136.
32. Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ. 1993. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res 629:95-102.
33. Keele CA, Armstrong D. 1964. Substances producing pain and itch. London: Edward Arnold Publisher.
34. Kemper RHA, Meijler WJ, Ter Horst GJ. 1997. Trigeminovascular stimulation in conscious rats. NeuroReport 8:1123-1126.
35. Kress M, Reeh PW. 1996. Chemical excitation and sensitization in nociceptors. In: Belmonte C, Cervero F, editors. Neurobiology of nociceptors. New York: Oxford University Press. p 258-297.
36. Kristhal OA, Pidoplichkio VI. 1980. A receptor for protons in the nerve cell membrane. Neuroscience 5:2325-2327.
37. Lambert GA, Zagami AS, Bogduk N, Lance JW. 1991. Cervical spinal cord neurons receiving input from the cranial vasculature. Cephalalgia 11:75-85.
38. Lang E, Novak A, Reeh PW, Handwerker HO. 1990. Chemosensitivity of fine afferents from rat skin in vitro. J Neurophysiol 63:887-901.
39. Leake JP, Loevenhart AS, Muehlberger CW. 1927. Dilatation of cerebral blood vessels as a factor in headache. JAMA 88:1076.
40. Levine JD, Taiwo Y, Collins SD, Tam JK. 1986. Noradrenaline hyperalgesia is mediated through the interaction with sympathetic postganglionic neuron terminals rather than activation of primary afferent nociceptors. Nature 323:158-160.
41. Liang Y-F, Haake B, Reeh PW. 2000. Sustained sensitization of rat cutaneous nociceptors by bradykinin and a novel theory of its excitatory action. J Physiol (Lond) (in press).
42. 1B-immunoreactivity within the human trigeminocerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia 17:833-842.
43. Manning DC, Raja SN, Meyer RA, Campell JN. 1991. Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin Pharmacol Therapeut 50:721-729.
44. Matsubara T, Moskowitz MA, Huang Z. 1992. UK-14,304, R(-)-alpha-methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms. Eur J Pharmacol 224:145-150.
45. McLeod RL, Aslanian R, del Prado M, Duffy R, Egan RW, Kreuter W, McQuade R, Hey JA. 1998. Sch50971, an orally active histamine H3 receptor agonist inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig. J Pharmacol Exp Ther 287:43-50.
46. McMahon MS, Norregaard TV, Beyerl BD, Borges LF, Moskowitz MA. 1985. Trigeminal afferents to cerebral arteries and forehead are not divergent axon collaterals in cat. Neurosci Lett 60:63-68.
47. 1) receptor agonist CP 93,129. Br J Pharmacol 125:1726-1732.
48. Messlinger K, Hanesch U, Kurosawa M, Pawlak M, Schmidt RF. 1995. Calcitonin gene-related peptide released from dural nerve fibers mediates increase of meningeal blood flow in the rat. Can J Physiol Pharmacol 73:1020-1024.
49. Moskowitz MA, Brody M, Liu-Chen L-Y. 1983. In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid. Neuroscience 9:809-814.
50. 1 receptor agonist, RP 67580. Eur J Pharmacol 238:421-424.
51. Nakamura-Craig M, Gill BK. 1991. Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw. Neurosci Lett 124:49-51.
52. Ness TJ, Gebhart GF. 1990. Visceral pain: a review of experimental studies. Pain 41:167-234.
53. Neugebauer V, Schaible H-G, Schmidt RF. 1989. Sensitization of articular afferents to mechanical stimuli by bradykinin. Pflügers Arch 415:330-335.
54. 1 receptor antagonist L-754,030) in the acute treatment of migraine. In: Abstracts of the 12th Migraine Trust Symposium, 1-4 September 1998, London.
55. 2 in the saliva of common migraine patients. Action of calcium channel blockers. Headache 29:498-501.
56. Ottosson A, Edvinsson L. 1997. Release of histamine from dural mast cells by substance P and calcitonin gene related peptide. Cephalalgia 17:166-174.
57. Pedersen-Bjergaard U, Nielsen LB, Jensen K, Edvinsson L, Jansen I, Olesen J. 1991. Calcitonin-gene related peptide, neurokinin A and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides 12:333-337.
58. Penfield W, McNaughton F. 1940. Dural headache and innervation of the dura mater. Arch Neurol Psychiatry 44:43-75.
59. Ray BS, Wolff HG. 1940. Experimental studies on headache. Arch Surg 41:813-856.
60. Reeh PW, Pethö G. 2000. Nociceptor excitation by thermal sensitization: a hypothesis. Progr Brain Res 29:39-50.
61. Rueff A, Dray A. 1993. Sensitization of peripheral afferent fibers in the in vitro neonatal rat spinal-cord tail by bradykinin and prostaglandins. Neuroscience 54:527-535.
62. Schade H. 1924. Die Molekularpathologie in ihrem Verhältnis zur Zellpathologie und zum klinischen Krankheitsbild am Beispiel der Entzündung. Münchener Med Wochensch 71:1-4.
63. Schaible H-G, Ebersberger A, Peppel P, Beck U, Messlinger K. 1997. Release of immunoreactive substance P in the trigeminal brain stem nuclear complex evoked by chemical stimulation of the nasal mucosa and the dura mater encephali: a study with antibody microprobes. Neuroscience 76:273-284.
64. Schepelmann K, Ebersberger A, Pawlak M, Oppmann M, Messlinger K. 1999. Response properties of trigeminal brain stem neurons with input from the dura mater encephali in the rat. Neuroscience 90: 543-554.
65. Schmelz M, Osiander G, Blunk J, Ringkamp M, Reeh PW, Handwerker HO. 1997. Intracutaneous injections of platelets cause acute pain and protracted hyperalgesia. Neurosci Lett 226:171-174.
66. 2B receptors: An early step in the generation of migraine headache? Eur J Neurosci 8:959-967.
67. Seno N, Dray A. 1993. Capsaicin induced activation of fine afferent fibers from rat skin in vitro. Neuroscience 55:563-569.
68. 1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br J Phamacol 108:11-12.
69. Smart D, Gunthrope MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB. 2000. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129:227-230.
70. Steranka LR, Manning DC, DeHaas CJ, Ferkany JW, Borosky SA, Connort JR, Vavrek RJ, Stewart JM, Snyder SH. 1988. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgetic actions. Proc Natl Acad Sci USA 85: 3245-3249.
71. 1B/D receptors. Chephalalgia 17:241.
72. Storer RJ, Goadsby PJ. 1997b. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat. Brain 120:2171-2177.
73. Strassman A, Mason P, Moskowitz M, Maciewitz R. 1986. Response of brain stem trigeminal neurons to electrical stimulation of the dura. Brain Res 379:242-250.
74. Strassman AM, Mineta Y, Vos BP. 1994a. Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat. J Neurosci 14:3725-3735.
75. Strassman AM, Potrebic S, Maciewitz RJ. 1994b. Anatomical properties of brain stem neurons that respond to electrical stimulation of dural blood vessels. J Comp Neurol 346: 349-365.
76. Strassman MA, Raymond SA, Burstein R. 1996. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384: 560-564.
77. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. 1997. Intravital microscopy studies on the effects of neurokinin agonists and calcitonin gene related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 17:525-531.
78. Yamamura H, Malick A, Chamberlin NL, Burstein R. 1999. Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine. J Neurophysiol 81:479-493.
79. Zagami AS, Lambert GA. 1990. Stimulation of cranial vessels excites nociceptive neurones in several thalamic nuclei. Exp Brain Res 81:552-566.
80. Zagami AS, Lambert GA. 1991. Craniovascular application of capsaicin activates nociceptive thalamic neurones in the rat. Neurosci Lett 121:187-190.
81. Zagami AS, Goadsby PJ, Edvinsson L. 1989. Extracranial peptide release following stimulation of the superior sagittal sinus in the cat. Cephalalgia 9:292-293.